In the hepatocellular carcinoma (HCC) microenvironment, chemokine receptors play a critical role in tumorigenesis and metastasis. Our previous studies have found that osteopontin (OPN) is a promoter for HCC metastasis. However, the role of chemokine receptors in OPN-induced HCC metastasis remains unclear. In this study, we demonstrate that OPN is dramatically elevated in HCC tissues with metastasis and that high expression of OPN correlates with poorer overall survival and higher recurrence rate. OPN upregulates chemokine receptor expression, migration, invasion and pulmonary metastasis in HCC. We find that C-C chemokine receptor type -
high probabilities of intrahepatic metastases and postoperative relapse. 2 Therefore, elucidating the mechanism of metastatic relapse of HCC is of great importance.
Osteopontin (OPN) is a secretary phosphorylated glycoprotein that is highly expressed in various human cancers. 5 In our previous studies, we have demonstrated that OPN is one of the leading genes that promote HCC metastasis, [6] [7] [8] [9] and elevated OPN levels in both HCC tissues and plasma are closely related to poor prognosis and postoperative tumor recurrence of HCC patients. 10, 11 Thus, understanding how OPN is involved in maintaining the metastatic phenotype of HCC cells may help to identify novel ways to combat HCC metastasis.
Chemokines and their receptors have been shown to play crucial roles not only in physiological cell migration but also in pathological processes, such as invasion and metastasis of cancer. 12 A growing body of research highlights their importance in determining the metastatic destination of cancers, including HCC. [13] [14] [15] Moreover, chemokine receptor antagonists have already been applied in clinical trials of inflammatory diseases and cancers. 16 Among them, C-C chemokine receptor type 1 (CCR1) and its 3
ligands, chemokine (C-C motif) ligand 3, 5 and 7 (CCL3, CCL5 and CCL7), have been characterized by the progression and metastasis of various of cancers. 17, 18 An increasing amount of preclinical evidence suggests that the inhibitory compounds of CCL3, CCL5, CCL7/CCR1 axis can be used for treatment of HCC and other tumors. [19] [20] [21] CCR1 is upregulated in human HCC tissues and animal HCC models. 18, 22, 23 Meanwhile, its ligands CCL3, CCL5 and CCL7 can promote HCC cell growth, migration and invasion. 18, [24] [25] [26] Moreover, the contribution of CCL3-CCR1 axis to HCC progression and metastasis is further confirmed in the diethylnitrosamine (DEN)-induced HCC model. 18, 22 In the present study, we aimed to explore the possible roles and functional mechanisms of CCR1 activation involved in OPN facilitating HCC metastasis.
2 | ME TH ODS
| Cell lines and cell culture
Immortalized liver cell line (LO 2 ) and human HCC cells (Hep3B, HepG2 and SMMC7721) were purchased from the Shanghai cell bank, Chinese Academy of Sciences (Shanghai, China). Additional human HCC cell lines (HCC97H and HCC-LM3) were obtained from the Liver Cancer Institute at Fudan University (Shanghai, China). Cells were cultured at 37°C with 5% CO 2 in DMEM supplemented with 10% FBS, 100 mg/mL penicillin and 100 mg/mL streptomycin.
| Immunohistochemical staining of human hepatocellular carcinoma tissue samples
Human HCC tissue specimens were obtained following the guidelines approved by the Ethics Committee of the Liver Cancer Institute, Fudan University, and written informed consent was obtained from patients in all cases. Immunohistochemical (IHC) staining was performed as described previously. 6 Briefly, tissue specimens were incubated using antibodies against OPN (1:200 dilution, Abcam, Cambridge, MA, USA), CCR1 (1:100 dilution, Novus, St. Louis, MO, USA) and a biotin-conjugated secondary antibody and then incubated with an avidin-biotin-peroxidase complex.
| Plasmid and cell transfections
Expression vectors for human OPN and CCR1 were constructed.
Human OPN or CCR1 was cloned into pWPI.1 lentiviral vectors. In addition, OPN shRNA, CCR1 shRNA, CXCR6 shRNA, and HIF-1a
shRNA and non-target shRNA control (pLKO.1 TRC, Mission RNAi)
were obtained commercially (Sigma-Aldrich, St. Louis, MO, USA).
The CCR1 promoter was generated from human genomic DNA by PCR, and was cloned into the MLUI and Hind III sites of the pGL3-Basic Vector. All constructs were confirmed by enzyme digestion and DNA sequencing. Detailed primers are presented in Table S2 . 
| Statistical analysis
All the analyses were performed using SPSS (Version 16; SPSS, Chicago, IL, USA). In IHC analysis, the Fisher exact test and Spearman rank correlation coefficient were used. Student's t-test was used to compare experimental data. The cumulative recurrence and survival rates were determined by using the Kaplan-Meier survival analyses and the log-rank test. Univariate and multivariate Cox proportional hazards models were performed to determine the independent factors that influence survival and recurrence. P < .05 was considered statistically significant. Additional methods are detailed in Document S1.
3 | RESULTS 3.1 | Osteopontin is positively associated with hepatocellular carcinoma metastasis in hepatocellular carcinoma patients
To evaluate the clinical outcomes of metastasis in HCC patients, we analyzed the survival of 96 HCC patients who received surgery (Table S1 ). The results showed that HCC patients within metastasis group had a significantly worse prognosis than the other patients ( Figure 1A ). As OPN is one of the leading genes that promote HCC metastasis, we examined OPN mRNA level in normal livers, tumors without metastasis and tumors with metastasis (n = 10 in each ZHU ET AL.
| 711 group; Figure 1B ). OPN levels were positively associated with HCC metastasis in HCC patients ( Figure 1B ). Moreover, we found significantly strong staining for OPN in the tumors with metastasis (Figure 1C,D) . Furthermore, upregulation of OPN was significantly associated with poorer overall survival and higher recurrence rates in HCC patients (P < .001, respectively; Figure 1E ,F). Collectively, these findings suggested that OPN was positively associated with metastasis and indicated poor prognosis in HCC patients.
is positively associated with metastasis in hepatocellular carcinoma patients. A, Cumulative overall survival of hepatocellular carcinoma patients with metastasis compared with those without metastasis over time, estimated using the Kaplan-Meier method and compared by the log-rank test. B, Relative mRNA levels of OPN measured by quantitative PCR analysis and normalized to b-actin, in normal livers, and in hepatocellular carcinoma tumors without and with metastasis (n = 10, respectively). Data are expressed as means AE SEM and compared using the unpaired t-test (**P < .01 and ***P < .001). C, Representative immunohistochemical (IHC) staining images showing the accumulation of OPN in normal liver, tumors without metastasis and tumors with metastasis. Scale bar, 100 lm. D, Statistical analysis of the pathologic scores of OPN in the various groups. Data are expressed as means AE SEM and compared using the unpaired t-test (**P < .01 and ***P < .001). E,F, Cumulative overall survival (E) and recurrence survival (F) of hepatocellular carcinoma patients with high or low OPN expression levels estimated using the Kaplan-Meier method and compared by the log-rank test. HCC, hepatocellular carcinoma Figure S2B ).
F I G U R E 3 CCR1, but not CXCR6, knockdown repressed osteopontin (OPN)-induced migration and invasion in hepatocellular carcinoma cells. SMMC7721, Hep3B and HepG2 cells were infected with lentiviral (LV) shCCR1, shCXCR6 or shRES to inhibit the expression of CCR1 and CXCR6 or rescue the expression of CCR1. shcontrol was used as a control. A, CCR1 and CXCR6 mRNA expression and protein expression levels were examined by quantitative PCR and western blot, respectively. B,C, Migration (B) and invasion (C) abilities of the indicated hepatocellular carcinoma (HCC) cells were determined by transwell assay. Data are expressed as means AE SEM of 3 independent experiments and compared using Student's t-test (*P < .05, **P < .01 and ***P < .001). OPN, osteopontin 3.5 | Osteopontin upregulates C-C chemokine receptor type 1 expression via phosphoinositide 3-kinase/AKT/hypoxia-inducible factor 1a pathway
We have determined that OPN overexpression could upregulate CCR1 expression in HCC cells. To elucidate the molecular mechanisms, HCC cells were transfected with a reporter plasmid containing the promoter of the human CCR1 gene, and we found that OPN upregulation significantly enhanced the promoter activity of CCR1 gene ( Figure 5A ).
Interestingly, we also found that CCR1 was highly expressed at the invasive front and significantly associated with hypoxic regions (detected by HIF-1a staining). Considering that hypoxia is a common feature that contributes to invasion and metastasis of cancers, including HCC, [28] [29] [30] we next analyzed the expression levels of HIF1a and CCR1 in HCC tissues and found that the CCR1 levels were closely correlated to HIF-1a levels ( Figure S3A To further elucidate the signaling pathways responsible for OPNinduced CCR1 expression in HCC, we treated HCC cells with several pathways inhibitors, which were reported to be activated by OPN. [31] [32] [33] [34] [35] The results revealed that only blocking the PI3K/AKT pathways by using LY294002 could significantly inhibit the OPN-induced CCR1 expression, while U0126 or SB203580 did not have similar effects ( Figure 5D ). In addition, ChIP-qPCR assay showed reduced binding of HIF-1a to the CCR1 promoter only in the presence of PI3K inhibitor, but not ERK or p38 inhibitors ( Figure 5E ). Taken together, these studies suggested that OPN upregulated CCR1 expression through the PI3K/AKT/HIF-1a signaling pathway (Figure 5A-E).
3.6 | C-C chemokine receptor type 1 is positively associated with hepatocellular carcinoma metastasis in hepatocellular carcinoma patients
To further investigate the role of CCR1 in HCC metastasis, we detected CCR1 expression in HCC cell lines with different metastatic potentials, and found that the CCR1 levels in high-metastatic HCC cell lines (HCC-97H and HCC-LM3) were much higher than those with low metastatic potential (HepG2, Hep3B and SMMC7721) (Figure 6A,B) . 36 Moreover, we measured mRNA levels of CCR1 by qPCR and IHC in normal livers, tumors without metastasis and tumors with metastasis, and found that CCR1 expression was significantly increased in the group of HCC with metastasis ( Figure 6C-E) . Furthermore, upregulation of CCR1 was significantly associated with poorer overall survival of the patients and higher recurrence rates (P < .001, respectively; Figure 6F ,G). Collectively, these findings suggested that CCR1 was positively associated with metastasis and indicated poor prognosis in HCC patients.
F I G U R E 4 CCR1 is essential for osteopontin (OPN)-induced hepatocellular carcinoma (HCC) metastasis. A-E, Downregulation of CCR1
decreased OPN-mediated HCC metastasis. A, After SMMC7721-OPN cells were infected with lentivirus (LV)-shCCR1 or LV-shcontrol, OPN and CCR1 expression was detected by western blot. B, Subcutaneous tumors with different cells were transplanted into the livers of nude mice. Representative images of the different groups are shown at 6 wk following orthotropic implantation. C1-C2, Overall survival of xenograft mice models of different groups using the Kaplan-Meier method and compared by the log-rank test. D, Representative HE staining images of lung tissues of different groups. Scale bar, 100 lm. E1, Incidence of lung metastases in the different groups. E2, Number of lung metastatic foci in each group. Error bars indicate means AESEM. *P < .05 and **P < .01. F-J, Upregulation of CCR1 rescued the decreased HCC metastasis induced by OPN knockdown. F, After HCC-97H-shOPN cells were infected with LV-CCR1 or LV-control, OPN and CCR1 expression was detected by western blot. G, Subcutaneous tumors with different cells were transplanted into the livers of nude mice. Representative images of the different groups are shown at 6 wk following orthotropic implantation. H1-H2, Overall survival of xenograft mice models of different groups using the Kaplan-Meier method and compared using the log-rank test. I, Representative HE staining images of lung tissues of different groups. Scale bar, 100 lm. J1, The incidence of lung metastases in the different groups. J2, Number of lung metastatic foci in each group. Error bars indicate means AE SEM. *P < .05 and **P < .01 ZHU ET AL.
| 715 F I G U R E 5 Osteopontin (OPN) upregulates CCR1 expression via PI3K/Akt/HIF-1a pathway. A, SMMC7721 cells with or without lentivirus (LV)-OPN were transiently transfected with a wild-type CCR1 promoter-dependent luciferase construct or a mutant construct wherein HIF-1a binding sites were mutated (WT: GGCACGTGCAG; MT: GGCATAGACAG). Luciferase activity was detected 24 h after LV-OPN transfection. B, SMMC7721-OPN cells were treated by HIF-1a inhibitor BAY 87-2243. The promoter activity and expression of CCR1 were measured by luciferase reporter assay, quantitative PCR (qPCR) and western blot, respectively. C, SMMC7721-OPN cells were transfected with HIF-1a shRNA or control shRNA. The promoter activity and expression of CCR1 were measured by luciferase reporter assay, qPCR and western blot, respectively. D, SMMC7721-OPN were treated by PI3K, ERK or p38 inhibitors. The expression of CCR1, phosphorylated and total AKT, ERK and p38 were analyzed by western blot. E, ChIP-qPCR of HIF-1a on the CCR1 promoter in the presence of LV-OPN and PI3K inhibitor. Data are expressed as means AE SEM and compared using Student's t-test (*P < .05, **P < .01 and ***P < .001) 3.7 | C-C chemokine receptor type 1 antagonist has more significant effects on hepatocellular carcinoma progression when osteopontin is upregulated
To further validate the essential roles of CCR1 in OPN-enhanced HCC progression, we evaluated the effects of BX471, a selective non-peptide CCR1 antagonist, on cell proliferation by the CCK-8 cell viability assay. 18, 22, 23 We found that BX471 could significantly inhi- Data are expressed as means AE SEM and compared using the unpaired t-test (**P < .01 and ***P < .001). E, Relative mRNA levels of CCR1 measured by qPCR analysis and normalized to b-actin, in normal livers, and in hepatocellular carcinoma tumors without and with metastasis (n = 10, respectively). Data are expressed as means AE SEM and compared using the unpaired t-test (**P < .01 and ***P < .001). F,G, The cumulative overall survival (F) and recurrence survival (G) of hepatocellular carcinoma patients with high or low CCR1 expression levels estimated using the Kaplan-Meier method and compared by the log-rank test 3.8 | Combination of osteopontin and C-C chemokine receptor type 1 has a better prediction performance for hepatocellular carcinoma prognosis
We further evaluated the association between OPN and CCR1 in HCC tissues. Immunohistochemistry (IHC) showed that OPN expression was positively correlated with CCR1 expression (Figure 8A,B) .
Based on the expression levels of OPN and CCR1, the HCC patients enrolled were divided into 3 groups. Kaplan-Meier analysis showed that patients with both high OPN and high CCR1 expression had the highest tumor recurrence rates and the shortest overall survival (Figure 8C,D) . Univariate analysis showed that OPN, CCR1 and serum GGT levels, tumor size, numbers and capsule were significantly associated with OS and DFS of HCC patients. Multivariate analysis showed that OPN, CCR1 expression, tumor size and combination of OPN and CCR1 were independent prognostic indicators for survival and recurrence (Table 1) as means AE SEM and compared using Student's t-test (*P < .05, **P < .01, ***P < .001) F I G U R E 8 Combination of osteopontin (OPN) and CCR1 has a better prediction performance for hepatocellular carcinoma (HCC) prognosis. A, Representative immunohistochemical (IHC) images showing the expression of OPN and CCR1 in HCC tissues. Scale bar, 50 lm. B, Association between the expression of OPN and CCR1 in HCC tissues. Significance was determined using the v 2 -test. C,D, HCC tissues with both high OPN and CCR1 level had poorer overall survival (C) and higher probability of recurrence (D) among the 3 subgroups. Significance was determined using the log-rank test. E, Representative IHC images of serial sections of liver from mice showing increased expression of OPN and CCR1 after diethylnitrosamine (DEN) compared with PBS treatment (12 mo). Scale bar, 100 lm. F, Working model for the role of OPN-CCR1 axis in HCC metastasis. OPN promotes HCC migration, invasion and metastasis by upregulating CCR1 through PI3K/AKT/HIF-1a signaling pathway, which is inhibited by CCR1 antagonist, BX471 pathways in HCC, which may contribute to tumor progression and metastases.
Osteopontin has been confirmed to play critical roles in HCC metastasis in the present as well as previous studies, and could be an ideal target to combat HCC metastasis. 9, 40, 44 However, targeting OPN in cancer with multiple inhibitors proved to be ineffective and frequently elicited unwanted adverse effects. 44, 45 In the present study, experiments. Given that CCR1 antagonist has more significant effects on HCC progression when OPN is upregulated, OPN can be used as biomarkers to predict the beneficial response to CCR1 blockade.
In conclusion, we have uncovered a new molecular mechanism of OPN in HCC metastasis ( Figure 8F ). OPN can activate CCR1 expression through the PI3K/AKT/HIF-1a signaling pathway to promote HCC progression and metastasis. CCR1 blockade is an alternative way to control the progression and metastasis of HCC with OPN overexpression.
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T A B L E 1 Univariate and multivariate analysis of factors associated with overall survival and disease-free survival in hepatocellular carcinoma patients AFP, a-fetoprotein; ALT, alanine transaminase; anti-HCV Ab, anti-hepatitis C virus antibody; CI, confidence interval; HBsAg, hepatitis B surface antigen; GGT, gamma-glutamyl transpeptidase; HR, hazard ratio; NA, not adopt. Univariate analysis, Cox proportional hazards regression model. **P < .05.
